Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Clinical trial NCT00284518 · COMPLETED

Trial details

NCT number: NCT00284518
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2005-12-01
Primary completion: 2009-05-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.